Population-based genomic study of Plasmodium vivax malaria in seven Brazilian states and across South America.

Amy Ibrahim ORCID logo; EmiliaManko; Jamille GDombrowski; MónicaCampos; Ernest DiezBenavente; DebbieNolder; Colin J Sutherland ORCID logo; FrancoisNosten; DianaFernandez; GabrielVélez-Tobón; +11 more... Alberto TobónCastaño; Anna Caroline CAguiar; Dhelio BatistaPereira; Simoneda Silva Santos; MarthaSuarez-Mutis; Silvia MariaDi Santi; AndreaRegina de Souza Baptista; Ricardo LuizDantas Machado; Claudio RFMarinho; Taane G Clark ORCID logo; Susana Campino ORCID logo; (2023) Population-based genomic study of Plasmodium vivax malaria in seven Brazilian states and across South America. Lancet regional health. Americas, 18. 100420-. ISSN 2667-193X DOI: 10.1016/j.lana.2022.100420
Copy

BACKGROUND: Brazil is a unique and understudied setting for malaria, with complex foci of transmission associated with human and environmental conditions. An understanding of the population genomic diversity of P. vivax parasites across Brazil can support malaria control strategies. METHODS: Through whole genome sequencing of P. vivax isolates across 7 Brazilian states, we use population genomic approaches to compare genetic diversity within country (n = 123), continent (6 countries, n = 315) and globally (26 countries, n = 885). FINDINGS: We confirm that South American isolates are distinct, have more ancestral populations than the other global regions, with differentiating mutations in genes under selective pressure linked to antimalarial drugs (pvmdr1, pvdhfr-ts) and mosquito vectors (pvcrmp3, pvP45/48, pvP47). We demonstrate Brazil as a distinct parasite population, with signals of selection including ABC transporter (PvABCI3) and PHIST exported proteins. INTERPRETATION: Brazil has a complex population structure, with evidence of P. simium infections and Amazonian parasites separating into multiple clusters. Overall, our work provides the first Brazil-wide analysis of P. vivax population structure and identifies important mutations, which can inform future research and control measures. FUNDING: AI is funded by an MRC LiD PhD studentship. TGC is funded by the Medical Research Council (Grant no. MR/M01360X/1, MR/N010469/1, MR/R025576/1, MR/R020973/1 and MR/X005895/1). SC is funded by Medical Research Council UK grants (MR/M01360X/1, MR/R025576/1, MR/R020973/1 and MR/X005895/1) and Bloomsbury SET (ref. CCF17-7779). FN is funded by The Shloklo Malaria Research Unit - part of the Mahidol Oxford Research Unit, supported by the Wellcome Trust (Grant no. 220211). ARSB is funded by São Paulo Research Foundation - FAPESP (Grant no. 2002/09546-1). RLDM is funded by Brazilian National Council for Scientific and Technological Development - CNPq (Grant no. 302353/2003-8 and 471605/2011-5); CRFM is funded by FAPESP (Grant no. 2020/06747-4) and CNPq (Grant no. 302917/2019-5 and 408636/2018-1); JGD is funded by FAPESP fellowships (2016/13465-0 and 2019/12068-5) and CNPq (Grant no. 409216/2018-6).



picture_as_pdf
Ibrabim_etal_2023_Population-based-genomic-study-of.pdf
subject
Published Version
Available under Creative Commons: 4.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work from this publication: